Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Baxter
Medtronic
Express Scripts
Moodys

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Dimethyltryptamine


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Dimethyltryptamine?

Dimethyltryptamine is an investigational drug.

There have been 19 clinical trials for Dimethyltryptamine. The most recent clinical trial was a Phase 2 trial, which was initiated on March 11th 2019.

The most common disease conditions in clinical trials are Depression, Depressive Disorder, and Depressive Disorder, Major. The leading clinical trial sponsors are Johns Hopkins University, Heffter Research Institute, and GH Research Limited.

There are one hundred and fifty-eight US patents protecting this investigational drug and nine hundred and ninety-one international patents.

Recent Clinical Trials for Dimethyltryptamine
TitleSponsorPhase
Psilocybin Therapy for Depression in Bipolar II DisorderUniversity of California, San FranciscoPhase 2
Single Ascending Dose Study With 5-MeO-DMT in Healthy SubjectsBeckley Psytech LimitedPhase 1
Psilocybin Therapy for Depression and Anxiety in Parkinson's DiseaseJoshua Woolley, MD/PhDPhase 2

See all Dimethyltryptamine clinical trials

Clinical Trial Summary for Dimethyltryptamine

Top disease conditions for Dimethyltryptamine
Top clinical trial sponsors for Dimethyltryptamine

See all Dimethyltryptamine clinical trials

US Patents for Dimethyltryptamine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Dimethyltryptamine ⤷  Try it Free Methods of improving behavioral therapies Emory University (Atlanta, GA) ⤷  Try it Free
Dimethyltryptamine ⤷  Try it Free Complex and structurally diverse compounds The Board of Trustees of the University of Illinois (Urbana, IL) ⤷  Try it Free
Dimethyltryptamine ⤷  Try it Free Factor XIa inhibitors Merck Sharp & Dohme Corp. (Rahway, NJ) ⤷  Try it Free
Dimethyltryptamine ⤷  Try it Free Pharmaceutical compositions resistant to abuse EGALET LTD. (London, GB) ⤷  Try it Free
Dimethyltryptamine ⤷  Try it Free Formulations of histone deacetylase inhibitor and uses thereof Pharmacyclics LLC (Sunnyvale, CA) ⤷  Try it Free
Dimethyltryptamine ⤷  Try it Free Methods, devices and systems for pulmonary delivery of active agents Syqe Medical Ltd. (Tel-Aviv, IL) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Dimethyltryptamine

Drugname Country Document Number Estimated Expiration Related US Patent
Dimethyltryptamine World Intellectual Property Organization (WIPO) WO2013142873 2032-03-23 ⤷  Try it Free
Dimethyltryptamine European Patent Office EP3134408 2034-04-22 ⤷  Try it Free
Dimethyltryptamine World Intellectual Property Organization (WIPO) WO2015164308 2034-04-22 ⤷  Try it Free
Dimethyltryptamine Australia AU2010211376 2029-02-06 ⤷  Try it Free
Dimethyltryptamine Australia AU2013257533 2029-02-06 ⤷  Try it Free
Dimethyltryptamine Canada CA2751627 2029-02-06 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Baxter
Medtronic
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.